General MedicationsORALGeneric

CHILDREN'S ALLEGRA HIVES

FEXOFENADINE HYDROCHLORIDE

Standard Dose

30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: N/A Marketing status: Discontinued

Summary

Approval overview CHILDREN'S ALLEGRA HIVES is listed in Drugs@FDA under application 201373 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient FEXOFENADINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CHATTEM SANOFI Submission history Latest submission status date: 2022-12-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview CHILDREN'S ALLEGRA HIVES is listed in Drugs@FDA under application 201373 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient FEXOFENADINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CHATTEM SANOFI Submission history Latest submission status date: 2022-12-27 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: N/A

Interaction Notes

No interaction notes stored yet.